Japan Plans For Enough H1N1 Flu Shots For 25 Million
This article was originally published in PharmAsia News
Executive SummaryJapan's plan to switch in mid-July from producing vaccines against seasonal flu viruses to producing H1N1 vaccines is expected to enable authorities to have enough vaccine on hand to protect 25 million people. The Health Ministry released data that said H1N1 vaccinations could begin in Japan as early as October. The H1N1 supply would be in addition to the stockpile of seasonal flu vaccines, which the ministry said are capable of protecting 40 million people. In January, the government expects to begin producing a vaccine against avian flu. (Click here for more - a subscription may be required
You may also be interested in...
Pfizer has confirmed the launch of its Trazimera trastuzumab biosimilar in the US. The rival to Herceptin will compete against not only the brand but also against two other biosimilars, with more on the way.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced January 2020.